Copyright
©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2791-2794
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2791
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2791
Figure 1 Survival curves of patients in control group and adjuvant TACE group without or with risk factors for residual tumor.
A: Survival curve of patients in control group and adjuvant TACE group without risk factor for residual tumor.B: Survival curve of patients in control group and adjuvant TACE group with risk factors for residual tumor.
- Citation: Ren ZG, Lin ZY, Xia JL, Ye SL, Ma ZC, Ye QH, Qin LX, Wu ZQ, Fan J, Tang ZY. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study. World J Gastroenterol 2004; 10(19): 2791-2794
- URL: https://www.wjgnet.com/1007-9327/full/v10/i19/2791.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i19.2791